Investment Analysts’ upgrades for Tuesday, September 5th:

The Navigators Group (NASDAQ:NAVG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $62.00 target price on the stock. According to Zacks, “The Navigators Group, Inc. is a holding company with twelve active wholly owned subsidiaries. They primarily write marine, onshore energy, engineering and construction insurance, and a contractors’ general liability program. As underwritten by Navigators, marine insurance includes hull, energy, liability and cargo; onshore energy primarily covers property damage with an emphasis on the oil and petrochemical sectors; and engineering and construction primarily covers construction projects including machinery, equipment and loss of use due to delays. “

NBT Bancorp (NASDAQ:NBTB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $37.00 target price on the stock. According to Zacks, “NBT BANCORP INC. is a one bank holding company engaged in general banking business. “

Minerva Neurosciences (NASDAQ:NERV) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $6.75 target price on the stock. According to Zacks, “Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company’s pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson’s disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States. “

Netshoes (CAYMAN) (NASDAQ:NETS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Netshoes (Cayman) Limited is a sports and lifestyle online retailer primarily in Latin America. The company’s product includes athletic shoes, jerseys, apparels, accessories and sporting equipment of international, local and private brands as well as fashion. It operates primarily in Brazil, Argentina and Mexico. Netshoes (Cayman) Limited is headquartered in São Paulo, Brazil. “

National Health Investors (NYSE:NHI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $90.00 target price on the stock. According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Bank of N.T. Butterfield & Son Limited (The) (NYSE:NTB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $37.00 target price on the stock. According to Zacks, “The Bank of N.T. Butterfield & Son Limited offers bank and wealth management services. It provides retail and corporate banking products and services as well as wealth management solutions comprising trust, private banking and asset management. The company operates primarily in Bermuda, the Cayman Islands, Guernsey, The Bahamas, Switzerland and the United Kingdom. The Bank of N.T. Butterfield & Son Limited is headquartered in Hamilton, Bermuda. “

Novogen Limited (NASDAQ:NVGN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “NOVOGEN LTD-ADR business is in the area of medicine know as degenerative diseases and disorders. Novogen is addressing this urgent area of medical need through the Novogen isoflavonoid technology platform – a platform that the Company believes offers the real prospect of not only treating, but also preventing, the onset of these common degenerative conditions. There are three divisions at Novagen: the pharmaceutical division, Marshall Edwards inc., and the consumer health division. “

Obic Co (NASDAQ:OBIIF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $51.00 price target on the stock. According to Zacks, “OBIC Co., Ltd provides system integration services, system support services, office automation services, and package software services. It also sells, leases and develops computers, peripherals, related systems and customized software. OBIC Co., Ltd is headquartered in Tokyo, Japan. “

OceanFirst Financial Corp. (NASDAQ:OCFC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $28.00 target price on the stock. According to Zacks, “OceanFirst Financial Corp. is a holding company for the OceanFirst Bank. “

Oil States International (NYSE:OIS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Oil States International, Inc. is a diversified oilfield services company. With locations around the world, Oil States is a leading manufacturer of products for deepwater production facilities and subsea pipelines, and a leading supplier of a broad range of services to the oil and gas industry, including production-related rental tools, work force accommodations and logistics, oil country tubular goods distribution and land drilling services. Oil States is organized in three business segments Offshore Products, Tubular Services and Well Site Services. “

Oriental Land (NASDAQ:OLCLY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $17.00 price target on the stock. According to Zacks, “Oriental Land Co., Ltd. operates and manages theme parks and hotels primarily in Japan. Oriental Land Co. is headquartered in Urayasu, Japan. “

Old Republic International Corporation (NYSE:ORI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Old Republic International Corporation is Chicago-based and is an insurance holding company whose subsidiaries market, underwrite and provide risk management services for a wide variety of coverages in the property and liability, mortgage guaranty, title and life and health insurance fields. “

ORIENT O/SEAS INTL (NASDAQ:OROVY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $51.00 price target on the stock. According to Zacks, “Orient Overseas (International) Limited through its subsidiaries operates as a provider of container transport and logistics services. Its principal business activities include container transport and logistics services, ports and terminals, and property investment. The Company also provides freight management services, extensive domestic distribution services and supply-chain management. It also operates container terminals which forms an integral part of its international containerized transportation business. Orient Overseas (International) Limited is headquartered in Wanchai, Hong Kong. “

Potbelly Corporation (NASDAQ:PBPB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Potbelly Corporation is a neighborhood sandwich concept. The Company manages establishments for consuming food on premises to offers sandwiches, salads, soups, chili, chips, cookies, ice cream, and smoothies. It serves customers throughout the United States. Potbelly Corporation is headquartered in Chicago, Illinois. “

Paddy Power Betfai (NASDAQ:PDYPY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Paddy Power Betfair Plc operates as an online betting and gaming company. Paddy Power Betfair Plc is headquartered in Dublin, Ireland. “

PennantPark Floating Rate Capital (NASDAQ:PFLT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $16.00 target price on the stock. According to Zacks, “PennantPark Floating Rate Capital Ltd. is a business development company. It is a closed-end, externally managed and non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing primarily in floating rate loans and other investments made to the United States middle-market companies. The firm provides first lien secured debt and other opportunistic financings (mezzanine, private high yield debt, preferred and common stock) to middle market sponsors and companies. Its investments may include equity features, such as direct investments in the equity securities of borrowers or warrants or options to buy a minority interest in a portfolio company. It has investments in various sectors, including aerospace and defense; consumer services; healthcare and pharmaceuticals, and others. The firm has a value-oriented, bottoms-up investment philosophy. Its investment activities are managed by the investment advisor, PennantPark Investment Advisers LLC. “

Pharming Group (NASDAQ:PHGUF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Pharming Group NV develops innovative therapeutics for the treatment of genetic disorders, specialty products for surgical indications and nutritional products. The advanced technologies of the Company include innovative and validated platforms for the production of protein therapeutics, technology and processes for the purification and formulation of its products. Its primary product Ruconest (R) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with hereditary angioedema in the European Union countries, Norway, Iceland and Liechtenstein. Pharming Group NV is headquartered in Leiden, the Netherlands. “

Premier (NASDAQ:PINC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. “

Plantronics (NYSE:PLT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Plantronics, Inc. is a leading designer, manufacturer and marketer of lightweight communications headsets and headset accessories and services. In addition, the company manufactures and markets specialty telephone products, such as amplified telephone handsets and specialty telephones for hearing-impaired users, and noise-canceling handsets for use in high-noise environments. “

ePlus inc. (NASDAQ:PLUS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $94.00 price target on the stock. According to Zacks, “ePlus Inc. serves as the parent holding company for ePlus Group, Inc., ePlus Technology of NC, Inc., ePlus Technology of PA, Inc., ePlus Technology, Inc., ePlus Government, Inc., ePlus Capital, Inc., ePlus Systems, Inc., ePlus Content Services, Inc and MLC Leasing, S.A. de C.V. “

Perficient (NASDAQ:PRFT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $20.00 price target on the stock. According to Zacks, “PERFICIENT INC helps clients acquire and strengthen customer relationships, reduce costs and empower employees by creating an Enabled Enterprise. Through their Enabled Enterprise solutions, Global 3000 companies can drive dramatic return-on-investment by unlocking the power of their existing enterprise resource planning and legacy systems. “

Ra Pharmctl (NASDAQ:RARX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ra Pharmaceuticals, Inc. is a biopharmaceutical company. It involved in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Ra Pharmaceuticals, Inc. is based in Cambridge, Massachusetts. “

Red Electrica Corporacion SA (OTCMKTS:RDEIY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $13.00 target price on the stock. According to Zacks, “Red Electrica Corporacion, S.A. is primarily engaged in power transmission and operation of electrical systems in Spain. The Company performs its functions in coordination with the operators and clients of the Iberian power market to ensure continuity and security of power supply. Red Eléctrica also acts as the operator of the insular and extra peninsular power systems. The Company also provides consulting and advisory services and telecommunication services through its subsidiaries. Red Electrica Corporacion, S.A. is headquartered in Alcobendas, Spain. “

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.